<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-96178" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ophthalmic Manifestations of Coronavirus (COVID-19)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hu</surname>
            <given-names>Katherine</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Jay</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Swiston</surname>
            <given-names>Cole</given-names>
          </name>
          <aff>John A Moran Eye Center, University of Utah Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Bhupendra C.</given-names>
          </name>
          <aff>University of Utah</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Katherine Hu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jay Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cole Swiston declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhupendra Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-96178.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>SARS-CoV-2, a novel enveloped, positive single-stranded RNA beta coronavirus, is the causative agent behind COVID-19. Amid the myriad symptoms associated with this disease, suspected ocular manifestations have garnered attention, leading to investigations into ocular signs, symptoms, and potential transmission routes. While direct contact with mucous membranes, including the eye, is thought to be a possible transmission route, conclusive evidence remains elusive. Complicating matters further, several reports have emerged suggesting that ocular manifestations&#x000a0;may be the sole indicator of COVID-19 illness in certain patients, underscoring the importance of vigilant ocular assessment in the diagnostic process.</p>
        <p>This activity delves into evaluating and managing ocular manifestations observed in COVID-19 cases. It aims to elucidate the diverse range of ocular signs and symptoms associated with the disease, offering insights into their clinical significance and implications for patient care. Furthermore, this activity highlights the pivotal role of the interprofessional healthcare team in effectively managing patients presenting with ocular manifestations of COVID-19, emphasizing the collaborative efforts required for optimal patient outcomes in this evolving clinical landscape.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Screen patients during routine clinical encounters for ocular symptoms suggestive of COVID-19 to aid in early detection and prevention of disease transmission.</p></list-item><list-item><p>Implement appropriate infection control measures in ophthalmic settings to mitigate the risk of COVID-19 transmission via ocular secretions.</p></list-item><list-item><p>Apply evidence-based guidelines for evaluating and managing ocular manifestations in patients with suspected or confirmed COVID-19.</p></list-item><list-item><p>Coordinate care and follow-up for COVID-19 patients with ocular symptoms to optimize outcomes and minimize disease spread within the community.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=96178&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=96178">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-96178.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Beginning in December 2019, COVID-19 developed into&#x000a0;a global pandemic caused by the highly transmissible SARS-CoV-2.<xref ref-type="bibr" rid="article-96178.r1">[1]</xref>&#x000a0;Numerous anecdotal and published reports initially indicated eye redness and irritation in patients with COVID-19,&#x000a0;supporting conjunctivitis as an ocular manifestation of SARS-CoV-2 infection. Ongoing reports&#x000a0;reveal associations between&#x000a0;COVID-19&#x000a0;and uveitic, retinovascular, and neuro-ophthalmic disease.</p>
        <p>During the 2003 severe acute respiratory&#x000a0;syndrome (SARS) outbreak, a study identified SARS-CoV in tear samples&#x000a0;collected in Singapore from patients with SARS.<xref ref-type="bibr" rid="article-96178.r2">[2]</xref>&#x000a0;The absence of eye protection&#x000a0;emerged as a primary risk factor for SARS-CoV transmission from patients to healthcare workers in Toronto,&#x000a0;raising concerns&#x000a0;about the potential for respiratory illnesses to be transmitted through ocular secretions.<xref ref-type="bibr" rid="article-96178.r3">[3]</xref><xref ref-type="bibr" rid="article-96178.r4">[4]</xref>&#x000a0;Similar concerns have been&#x000a0;expressed&#x000a0;regarding SARS-CoV-2,&#x000a0;particularly among eye care providers and frontline personnel responsible for assessing patients with the potential initial symptoms of COVID-19.</p>
        <p>Dr Li Wenliang, an opthalmologist, was among the first to express apprehensions about the coronavirus transmission in Chinese patients. Unfortunately, he succumbed to COVID-19, and it was suspected that he contracted the virus from an asymptomatic glaucoma patient in his clinic.<xref ref-type="bibr" rid="article-96178.r5">[5]</xref></p>
      </sec>
      <sec id="article-96178.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>SARS-CoV-2 is an enveloped, positive single-stranded RNA beta coronavirus responsible for causing COVID-19 (see <bold>Image.&#x000a0;</bold>Structure of COVID-19). It was initially associated&#x000a0;with an outbreak in Wuhan, located in China's Hubei province.<xref ref-type="bibr" rid="article-96178.r1">[1]</xref> Direct contact with mucous membranes, including the eye, is a suspected transmission route.</p>
        <p>Coronaviruses&#x000a0;have been known to&#x000a0;cause severe ocular diseases in animals,&#x000a0;leading to anterior uveitis, retinitis, vasculitis, and optic neuritis in feline and murine species. In contrast, ocular manifestations in humans are typically mild and rare,&#x000a0;although there&#x000a0;is a growing&#x000a0;number of&#x000a0;reported ocular findings in&#x000a0;individuals who test positive for COVID-19.<xref ref-type="bibr" rid="article-96178.r6">[6]</xref>&#x000a0;</p>
        <p>No ocular manifestations of Middle East respiratory syndrome (MERS) or SARS have been reported. However, as&#x000a0;mentioned&#x000a0;earlier, SARS-CoV was identified in ocular secretions.<xref ref-type="bibr" rid="article-96178.r2">[2]</xref> Other coronaviruses have been found to cause viral conjunctivitis in humans.<xref ref-type="bibr" rid="article-96178.r7">[7]</xref></p>
      </sec>
      <sec id="article-96178.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>As of April 4, 2020,&#x000a0;the World Health Organization (WHO) reported&#x000a0;1,272,953&#x000a0;confirmed cases and 69,428&#x000a0;deaths worldwide due to COVID-19, with an additional 79,332 new cases confirmed in the preceding&#x000a0;24 hours. Meanwhile, the Centers for Disease Control and Prevention (CDC) had documented 337,278 cases and 9637 deaths in the United States up to that date.</p>
        <p>On April 16, 2021,&#x000a0;slightly over a year later, the global death toll surpassed the 3 million mark. The&#x000a0;gravity of the pandemic is&#x000a0;underscored by noting the rate of fatalities: it took 8.5 months&#x000a0;from the first fatality in China to reach the initial 1 million lives lost, 3.5 months to reach 2 million, and just&#x000a0;3 months&#x000a0;to exceed the 3 million lives lost milestone.&#x000a0;</p>
        <p>As of December 23, 2021, the US has reported 51,574,787 confirmed cases of COVID-19 and 809,300 deaths. Globally,&#x000a0;the WHO has documented over&#x000a0;276 million confirmed cases and 5,374,744 deaths due to COVID-19. Additionally, 8,649,057,088 vaccine doses have been administered worldwide by that date. The United States leads in the number of infections, followed by India, Brazil, the United Kingdom, Russia, Turkey, and France.</p>
        <p>Viral mutations leading to variants of SARS-CoV-2 have been&#x000a0;identified globally, including the B.1.1.7 variant in the United Kingdom in early 2020, the B.1.526 variant in the United States in November 2020, the B.1.525 variant in the United Kingdom and Nigeria in December 2020, and the B.1.351 variant in South Africa in late 2020. The Delta variant, B.1.617.2, was&#x000a0;first identified in India in December 2020 and rapidly spread&#x000a0;across over 60 countries due to a 40% to 60% increase in transmissibility, becoming the predominant strain&#x000a0;worldwide by August 2021.<xref ref-type="bibr" rid="article-96178.r8">[8]</xref> Most recently, the Omicron variant, B.1.1.529, was&#x000a0;designated a variant of concern in late November 2021&#x000a0;following cases that emerged from Botswana and South Africa, showing rapid and exponential spread.<xref ref-type="bibr" rid="article-96178.r9">[9]</xref></p>
        <p>Initial&#x000a0;studies postulated that ocular manifestations of COVID-19 were infrequent. Only 9 (0.8%) out of 1099 patients from 552 hospitals across 30 provinces in China were reported to&#x000a0;exhibit conjunctival congestion from December 2019 through January 2020.<xref ref-type="bibr" rid="article-96178.r10">[10]</xref>&#x000a0;Recent data, however, indicate a&#x000a0;significantly higher incidence of ocular signs and symptoms. A 2021 meta-analysis by Nasiri et al reported a pooled prevalence of all ocular manifestations among 7300 COVID-19 patients as 11.03%, with conjunctivitis being the most frequent ocular disease (88.8%).<xref ref-type="bibr" rid="article-96178.r11">[11]</xref>&#x000a0;In the same meta-analysis, other common symptoms included dry eye or foreign body sensation (16%), eye redness (13.3%), tearing (12.8%), and itching (12.6%).</p>
        <p>In a case series involving 38 hospitalized patients with COVID-19 in Hubei province, China,&#x000a0; ocular symptoms&#x000a0;were reported in 12 individuals (31.6%).<xref ref-type="bibr" rid="article-96178.r12">[12]</xref>&#x000a0;These patients&#x000a0;exhibited conjunctival hyperemia (3 patients), chemosis (7 patients), epiphora (7 patients), or increased secretions (7 patients). Notably, only 1&#x000a0;patient presented with epiphora as the&#x000a0;initial symptom of COVID-19.&#x000a0;Among those with ocular manifestations, 2 patients (16.7%)&#x000a0;tested positive&#x000a0;for SARS-CoV-2&#x000a0;through reverse-transcriptase polymerase chain reaction (RT-PCR) using a conjunctival swab and nasopharyngeal swabs. Only&#x000a0;1 patient in&#x000a0;the study presented with conjunctivitis as the first symptom.<xref ref-type="bibr" rid="article-96178.r12">[12]</xref>&#x000a0;The authors&#x000a0;observed that patients with ocular symptoms had higher white blood cell and neutrophil counts, C-reactive protein, and&#x000a0;elevated levels of procalcitonin and lactate dehydrogenase than patients without ocular abnormalities.&#x000a0;</p>
        <p>In a study by Xia et al involving 30 hospitalized patients with COVID-19, 1 patient tested positive for SARS-CoV-2 in ocular secretions&#x000a0;through a conjunctival swab. This patient did not&#x000a0;present&#x000a0;with&#x000a0;severe fever or respiratory symptoms during testing.<xref ref-type="bibr" rid="article-96178.r13">[13]</xref></p>
        <p>Among ocular manifestations of the disease, conjunctivitis and keratoconjunctivitis are the most prevalent ocular symptoms in adults.<xref ref-type="bibr" rid="article-96178.r14">[14]</xref>&#x000a0;The most common ophthalmological findings include conjunctival irritation&#x000a0;followed by diplopia and cotton wool patches.<xref ref-type="bibr" rid="article-96178.r14">[14]</xref></p>
      </sec>
      <sec id="article-96178.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis and tissue tropism of SARS-CoV-2&#x000a0;are linked to the interaction between the viral spike protein and its cognate receptor on human host cells&#x02014; the angiotensin-converting enzyme 2 (ACE-2) receptor. Efficient cell entry requires cleavage by the protein transmembrane serine protease 2 (TMPRSS2). ACE-2 expression is predominant in respiratory mucosal and alveolar epithelial cells&#x000a0;but&#x000a0;has also been identified in other tissues, including the gastrointestinal tract, kidney, vascular endothelial cells, immune cells, and even neurons. Virulence is achieved&#x000a0;through direct cellular invasion and death and the induction of widespread cytokine-driven inflammation and vascular leakage.<xref ref-type="bibr" rid="article-96178.r15">[15]</xref>&#x000a0;Additionally, immune cell and complement debris&#x000a0;may contribute&#x000a0;to an increased thromboembolic state.</p>
        <p>The potential&#x000a0;for infection through ocular secretions is currently unknown, and&#x000a0;the mechanisms by which&#x000a0;SARS-CoV-2 accumulates in ocular secretions are not fully understood.&#x000a0;Several theories have been proposed, including direct inoculation of ocular tissues from respiratory droplets or aerosolized viral particles, migration from the nasopharynx&#x000a0;from the nasolacrimal duct, or even hematogenous spread through the lacrimal gland.<xref ref-type="bibr" rid="article-96178.r6">[6]</xref></p>
        <p>Data surrounding the expression of ACE-2 and TMPRSS2 on the ocular surface are varied. While a study&#x000a0;showed the presence of both&#x000a0;proteins on the cornea and limbus, low levels were noted in the conjunctiva.<xref ref-type="bibr" rid="article-96178.r16">[16]</xref> Lange et al&#x000a0;similarly&#x000a0;reported low levels of ACE-2 in&#x000a0;the human conjunctiva.<xref ref-type="bibr" rid="article-96178.r17">[17]</xref></p>
        <p>A case report from Rome, Italy, documented the&#x000a0;isolation of SARS-CoV-2 by RT-PCR from conjunctival swabs in a patient with COVID-19 exhibiting ocular symptoms.<xref ref-type="bibr" rid="article-96178.r18">[18]</xref> Conjunctival swabs were collected from the hospital on days 3&#x000a0;to&#x000a0;27. Despite clinical resolution of conjunctivitis by day 20, the patient had detectable SARS-CoV-2 RNA in conjunctival samples on day 21 and subsequently on day 27, even after SARS-CoV-2 was&#x000a0;no longer detectable by nasopharyngeal swab.&#x000a0;Notably, the viability and transmissibility of&#x000a0;SARS-CoV-2 in human ocular secretions remain uncertain since the virus has not been successfully cultured from human tears or conjunctival swabs.<xref ref-type="bibr" rid="article-96178.r19">[19]</xref> Limited reports suggest that tears can&#x000a0;serve as both an early and late source of infection transmission, even after the patient becomes asymptomatic.<xref ref-type="bibr" rid="article-96178.r18">[18]</xref><xref ref-type="bibr" rid="article-96178.r20">[20]</xref></p>
        <p>In a study by&#x000a0;Azzolini et al, SARS-CoV-2&#x000a0;was identified&#x000a0;on the ocular surface using RT-PCR in 52 of 91 patients with COVID-19 (57.1%).<xref ref-type="bibr" rid="article-96178.r5">[5]</xref>&#x000a0;The virus was&#x000a0;detected on the ocular surface in 10 of 17 patients, even when the nasopharyngeal swab&#x000a0;results were&#x000a0;negative.&#x000a0;Viral particles in tears&#x000a0;have been postulated&#x000a0;to originate from the lacrimal gland through diffusion from a systemic viral load or direct&#x000a0;contagion from airborne droplets.<xref ref-type="bibr" rid="article-96178.r5">[5]</xref></p>
      </sec>
      <sec id="article-96178.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The prevalence of ocular manifestations in patients with COVID-19 varies widely, ranging from 2% to 32% in reported studies.<xref ref-type="bibr" rid="article-96178.r21">[21]</xref><xref ref-type="bibr" rid="article-96178.r22">[22]</xref><xref ref-type="bibr" rid="article-96178.r23">[23]</xref>&#x000a0;These variations underscore the importance of ongoing research to understand better the frequency and nature of ocular involvement in patients with COVID-19.</p>
        <p>
<bold>Conjunctiva</bold>
</p>
        <p>Individuals&#x000a0;infected with SARS-CoV-2 may present with acute conjunctivitis symptoms, including eye redness, ocular irritation, soreness, foreign body sensation, tearing, mucoid discharge, eyelid swelling, congestion, and&#x000a0;chemosis.&#x000a0;While these symptoms more commonly occur in patients with severe systemic symptoms of COVID-19, they can occasionally present as an initial manifestation of the disease.<xref ref-type="bibr" rid="article-96178.r12">[12]</xref>&#x000a0;</p>
        <p>Notably, unremitting conjunctivitis was&#x000a0;identified&#x000a0;as the sole manifestation of COVID-19 in 5 patients with confirmed SARS-CoV-2 infection through nasopharyngeal RT-PCR. These patients never developed fever, general malaise, or respiratory symptoms throughout their illness.<xref ref-type="bibr" rid="article-96178.r24">[24]</xref></p>
        <p>Examination findings&#x000a0;may include features&#x000a0;consistent with mild follicular conjunctivitis,&#x000a0;such as unilateral or bilateral bulbar conjunctiva injection, follicular reaction of the palpebral conjunctiva, watery discharge, and mild eyelid edema. Bilateral chemosis alone may represent third-spacing in a critically ill patient rather than a true ocular manifestation of the virus.&#x000a0;</p>
        <p>A case report by Cheema et al&#x000a0;documented the first keratoconjunctivitis as the presenting manifestation of COVID-19 in North America.<xref ref-type="bibr" rid="article-96178.r25">[25]</xref>&#x000a0;The patient primarily presented with symptoms&#x000a0;of eye redness and tearing. The examination revealed conjunctival injection,&#x000a0;a follicular reaction of the palpebral conjunctiva, and corneal findings that developed rapidly over&#x000a0;3 days. These corneal findings included transient pseudodendritic lesions and diffuse subepithelial infiltrates with overlying epithelial defects.</p>
        <p>Severe hemorrhagic conjunctivitis and pseudomembrane formation&#x000a0;have also&#x000a0;manifested 19 days after the onset of COVID-19 systemic symptoms and 11 days after admission to the intensive care unit.<xref ref-type="bibr" rid="article-96178.r26">[26]</xref>&#x000a0;Notably,&#x000a0;in pediatric patients, COVID-19 has been strongly associated with the Kawasaki-like illness known as multisystem inflammatory syndrome in children (MIS-C). Several ocular manifestations, including papilledema, iritis, and keratitis,&#x000a0;have been reported in this syndrome, with conjunctivitis being the most prevalent ocular manifestation.<xref ref-type="bibr" rid="article-96178.r27">[27]</xref></p>
        <p>
<bold>Sclera/Episclera</bold>
</p>
        <p>Epsicleritis and scleritis are findings associated with COVID-19 infection. Unilateral and nodular episcleritis have been&#x000a0;observed at the onset of symptoms.<xref ref-type="bibr" rid="article-96178.r28">[28]</xref><xref ref-type="bibr" rid="article-96178.r29">[29]</xref></p>
        <p>Necrotizing anterior scleritis can manifest as late as&#x000a0;3 weeks after the onset of viral symptoms.<xref ref-type="bibr" rid="article-96178.r30">[30]</xref>&#x000a0;Moreover, sectoral anterior scleritis has been&#x000a0;reported up to 2 weeks after the onset of COVID-19, with noted improvement following treatment with topical and systemic steroids.<xref ref-type="bibr" rid="article-96178.r30">[30]</xref></p>
        <p>
<bold>Anterior Chamber</bold>
</p>
        <p>In addition to affecting the ocular surface, acute anterior uveitis has been reported independently and&#x000a0;associated&#x000a0;with COVID-19-related multisystem inflammatory disease.<xref ref-type="bibr" rid="article-96178.r31">[31]</xref><xref ref-type="bibr" rid="article-96178.r32">[32]</xref>&#x000a0;A&#x000a0;documented case of reactivated idiopathic anterior uveitis following COVID-19 infection has also been reported. Notably, this patient had remained quiescent for 13 years before&#x000a0;the occurrence of this episode.<xref ref-type="bibr" rid="article-96178.r33">[33]</xref></p>
        <p>
<bold>Retina and Choroid</bold>
</p>
        <p>Posterior segment diseases have also been suspected in association with COVID-19 infection, exhibiting diverse etiologies, including vascular, inflammatory, and neuronal involvement. Both ACE-2 and TMPRSS2 are&#x000a0;prominently expressed in the human retina. A recent case series&#x000a0;involving&#x000a0;3 patients&#x000a0;identified S and N COVID-19 proteins&#x000a0;through immunofluorescence microscopy within retinal vascular endothelial cells,&#x000a0;suggesting the presence of&#x000a0;viral particles.<xref ref-type="bibr" rid="article-96178.r34">[34]</xref><xref ref-type="bibr" rid="article-96178.r35">[35]</xref></p>
        <p>Reports of both&#x000a0;central retinal vein and artery occlusions have&#x000a0;emerged&#x000a0;in patients without typical systemic vascular risk factors. The hypothesized mechanism&#x000a0;involves a complement-induced prothrombic and inflammatory state induced by the virus, resulting in endothelial damage and microangiopathic injury. A striking example by Walinjkar et al&#x000a0;featured a central retinal vein occlusion in a 17-year-old female with COVID-19.<xref ref-type="bibr" rid="article-96178.r36">[36]</xref>&#x000a0;A similar case&#x000a0;was seen in a previously healthy 33-year-old individual.<xref ref-type="bibr" rid="article-96178.r37">[37]</xref>&#x000a0;Additionally, there have been multiple instances of&#x000a0;central retinal artery occlusions reported, potentially related to viral-induced endothelial insult and vasculitis.<xref ref-type="bibr" rid="article-96178.r38">[38]</xref><xref ref-type="bibr" rid="article-96178.r39">[39]</xref><xref ref-type="bibr" rid="article-96178.r40">[40]</xref></p>
        <p>Acute macular neuroretinopathy (AMN) and paracentral acute middle maculopathy (PAMM), conditions&#x000a0;characterized by ischemia in&#x000a0;the deep retinal capillary plexus, have been observed with COVID-19. Hyperreflective changes at the level of the outer plexiform and inner nuclear layers identify these conditions.<xref ref-type="bibr" rid="article-96178.r41">[41]</xref></p>
        <p>Purtscher-like retinopathy may manifest with findings of multiple bilateral cotton wool spots localized&#x000a0;to the posterior pole. This condition&#x000a0;typically occurs in patients with prolonged hospitalization&#x000a0;and&#x000a0;severe complications, including multiorgan failure and disseminated intravascular coagulation.<xref ref-type="bibr" rid="article-96178.r42">[42]</xref><xref ref-type="bibr" rid="article-96178.r43">[43]</xref></p>
        <p>Optical coherence tomography (OCT)&#x000a0;revealed&#x000a0;subclinical hyperreflective lesions at the inner plexiform and ganglion cell layer level in 12 adults examined after systemic disease onset. Additionally, cotton wool spots and microhemorrhages were&#x000a0;identified on dilated fundus examinations in 4 of these patients.<xref ref-type="bibr" rid="article-96178.r44">[44]</xref>&#x000a0;In a study by Invernizzi and colleagues, retinal findings such as hemorrhages (9.25%), cotton wools spots (7.4%), dilated veins (27.7%), and tortuous vessels (12.9%)&#x000a0;were observed&#x000a0;in 54 patients with COVID-19 upon screening&#x000a0;during fundus photography screening.<xref ref-type="bibr" rid="article-96178.r45">[45]</xref></p>
        <p>These authors also found&#x000a0;a direct correlation between&#x000a0;retinal vein diameter&#x000a0;and disease severity, suggesting that&#x000a0;monitoring retinal vein diameter could be a&#x000a0;noninvasive parameter&#x000a0;for&#x000a0;assessing the&#x000a0;inflammatory response or endothelial injury in COVID-19. Lecler et al&#x000a0;documented&#x000a0;abnormal MRI findings in the posterior pole of 9 patients with COVID-19 consisting of&#x000a0;1 or several hyperintense nodules in the macular region on FLAIR-weighted images.<xref ref-type="bibr" rid="article-96178.r46">[46]</xref> These lesions were postulated to be either direct inflammatory infiltration of the retina or microangiopathic disease&#x000a0;caused by viral infection.</p>
        <p>Various forms of posterior uveitis have been observed following either acute COVID-19 infection or administration of the COVID-19 vaccine. Souza et al reported a case of unilateral multifocal choroiditis,&#x000a0;although the temporal relationship of the viral infection could be attributed to chance alone.<xref ref-type="bibr" rid="article-96178.r47">[47]</xref>&#x000a0;Additionally, Goyal et al published a case of bilateral multifocal choroiditis within&#x000a0;1 week of&#x000a0;receiving the COVID-19 vaccine.<xref ref-type="bibr" rid="article-96178.r48">[48]</xref>&#x000a0;Furthermore, cases of serpiginous and ampiginous choroiditis have also been reported.<xref ref-type="bibr" rid="article-96178.r49">[49]</xref><xref ref-type="bibr" rid="article-96178.r50">[50]</xref></p>
        <p>Immune dysregulation&#x000a0;resulting from&#x000a0;COVID-19 infection may contribute to the reactivation of latent herpes virus, leading to acute retinal necrosis.<xref ref-type="bibr" rid="article-96178.r51">[51]</xref>&#x000a0;These cases highlight the importance of vigilance for potential viral reactivation and associated ocular complications in individuals with COVID-19.</p>
        <p>Animal model studies have&#x000a0;demonstrated&#x000a0;the involvement of the retina in COVID-19 patients, revealing&#x000a0;retinal vasculitis, retinal degeneration, and breakdown of the blood-retinal barrier.<xref ref-type="bibr" rid="article-96178.r52">[52]</xref><xref ref-type="bibr" rid="article-96178.r53">[53]</xref><xref ref-type="bibr" rid="article-96178.r54">[54]</xref>&#x000a0;These findings provide valuable insights into the pathophysiology of&#x000a0;retinal complications associated with the virus.</p>
        <p>
<bold>Optic Nerve</bold>
</p>
        <p>Various neuro-ophthalmologic manifestations have been&#x000a0;observed in association with COVID-19,&#x000a0;primarily related to demyelinating disease. While the mechanism of these manifestations is unclear, hypotheses include direct neuronal invasion, endothelial cell dysfunction leading to ischemia and coagulopathy, or a widespread inflammatory "cytokine storm" induced by the virus.<xref ref-type="bibr" rid="article-96178.r55">[55]</xref> Optic neuritis has&#x000a0;been reported&#x000a0;in several patients with the infection, alongside neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibodies.<xref ref-type="bibr" rid="article-96178.r56">[56]</xref><xref ref-type="bibr" rid="article-96178.r57">[57]</xref><xref ref-type="bibr" rid="article-96178.r58">[58]</xref>&#x000a0;</p>
        <p>Patients have presented with subacute vision loss, a relative afferent pupillary defect, pain with eye movements, optic disc edema, and radiographic findings of acute optic neuritis following COVID-19 infection. Additionally, there have been reports of acute optic neuritis following vaccination for COVID-19.<xref ref-type="bibr" rid="article-96178.r59">[59]</xref></p>
        <p>Palao et al reported a case of multiple sclerosis following COVID-19 infection in a 24-year-old patient who presented with right optic neuritis. MRI&#x000a0;revealed right optic nerve inflammation and supratentorial periventricular demyelinating lesions.<xref ref-type="bibr" rid="article-96178.r60">[60]</xref> These cases suggest&#x000a0;a potential link between SARS-CoV-2&#x000a0;infection and the initiation or&#x000a0;exacerbation of inflammatory and demyelinating disease.</p>
        <p>Ophthalmologists&#x000a0;should&#x000a0;be&#x000a0;consulted to&#x000a0;assess for papilledema in patients infected with SARS-CoV-2, as cases of elevated intracranial pressure have been reported. This elevation can stem from widespread inflammation and dural venous sinus thrombosis.<xref ref-type="bibr" rid="article-96178.r61">[61]</xref>&#x000a0;Furthermore,&#x000a0;MIS-C&#x000a0;associated&#x000a0;with COVID-19 is&#x000a0;increasingly&#x000a0;recognized as a&#x000a0;distinct syndrome similar to Kawasaki disease and has been linked to both optic neuritis and elevated intracranial pressure.<xref ref-type="bibr" rid="article-96178.r62">[62]</xref></p>
        <p>Another example&#x000a0;involves a young patient who developed&#x000a0;pseudotumor cerebri syndrome associated with MIS-C due to COVID-19. The patient presented with a new right abducens palsy, papilledema with disc hemorrhages, and a lumbar puncture&#x000a0;revealing an opening pressure of 36 cm H2O.<xref ref-type="bibr" rid="article-96178.r63">[63]</xref></p>
        <p>
<bold>Extraocular Motility, Cranial Nerves</bold>
</p>
        <p>Cranial nerve III, IV, and VI palsies associated with COVID-19 have been reported in the literature, often occurring within a few days of fever and cough onset, with most cases lacking remarkable radiological features.<xref ref-type="bibr" rid="article-96178.r64">[64]</xref><xref ref-type="bibr" rid="article-96178.r65">[65]</xref><xref ref-type="bibr" rid="article-96178.r66">[66]</xref>&#x000a0;Ocular cranial neuropathies and binocular diplopia with nerve enhancement on MRI have also been observed in association with postinfectious demyelinating conditions such as Miller-Fisher and Guillain Barr&#x000e9; syndromes. Presenting&#x000a0;signs&#x000a0;include&#x000a0;one-sided&#x000a0;mydriasis, ptosis, and limited depression and adduction&#x000a0;alongside concurrent MRI enhancement of the corresponding oculomotor nerve.<xref ref-type="bibr" rid="article-96178.r67">[67]</xref>&#x000a0;Lower extremity hyporeflexia and ataxia are also consistent with Miller-Fisher syndrome.</p>
        <p>Ocular myasthenia gravis&#x000a0;is a postinfectious sequela of COVID-19, with researchers proposing that antibodies targeting SARS-CoV-2 proteins may cross-react with acetylcholine receptors and similar components at the neuromuscular junction.<xref ref-type="bibr" rid="article-96178.r68">[68]</xref>&#x000a0;The condition&#x000a0;can be&#x000a0;successfully managed with intravenous immunoglobulins and oral pyridostigmine.<xref ref-type="bibr" rid="article-96178.r69">[69]</xref></p>
        <p>
<bold>Pupils</bold>
</p>
        <p>Patients with COVID-19 may exhibit pupillary changes such as mydriasis and cholinergic super-sensitivity, indicating tonic pupils and postganglionic parasympathetic pupillary nerve fiber damage.<xref ref-type="bibr" rid="article-96178.r70">[70]</xref><xref ref-type="bibr" rid="article-96178.r71">[71]</xref><xref ref-type="bibr" rid="article-96178.r72">[72]</xref>&#x000a0;These changes underscore the diverse neurological implications of SARS-CoV-2 infection.</p>
        <p>
<bold>Nystagmus</bold>
</p>
        <p>Visual disturbances such as oscillopsia&#x000a0;can be&#x000a0;observed in COVID-19 patients with neurologic involvement. Viral-induced vestibular neuritis can manifest as intractable vertigo, nausea, and vomiting.<xref ref-type="bibr" rid="article-96178.r73">[73]</xref> Central vestibular nystagmus is also associated with clinical and imaging findings consistent with rhombencephalitis.<xref ref-type="bibr" rid="article-96178.r74">[74]</xref><xref ref-type="bibr" rid="article-96178.r75">[75]</xref></p>
        <p>
<bold>Visual Cortex</bold>
</p>
        <p>Perhaps the most devastating neuro-ophthalmic complication of severe COVID-19 infection is acute stroke affecting the posterior visual pathways.&#x000a0;Studies indicate that the incidence of stroke in these patients&#x000a0;is 7.6 times higher than that of patients with influenza, occurring in a notably younger-than-average patient population without classic vascular risk factors.<xref ref-type="bibr" rid="article-96178.r76">[76]</xref>&#x000a0;Patients may present with homonymous visual field deficits, prompting ophthalmologic consultation.&#x000a0;One example is a&#x000a0;recently published&#x000a0;case&#x000a0;involving a 12-year-old patient with MIS-C related to COVID-19, who presented with bilateral posterior cerebral artery ischemic strokes presenting as a homonymous visual field defect.<xref ref-type="bibr" rid="article-96178.r77">[77]</xref></p>
        <p>
<bold>Orbit and Ocular Adnexa</bold>
</p>
        <p>While oculoplastic and orbital manifestations of COVID-19 are rare,&#x000a0;emerging evidence suggests a potential association between the virus and inflammatory&#x000a0;or infectious disease. There have been&#x000a0;2 reported cases of sinusitis, orbital cellulitis, and intracranial abnormalities in adolescents with COVID-19.<xref ref-type="bibr" rid="article-96178.r78">[78]</xref>&#x000a0;</p>
        <p>This study hypothesized&#x000a0;that SARS-CoV-2 infection could result in congestion of the upper respiratory tract, increasing the risk&#x000a0;of secondary bacterial infection. This theory was expanded on by Shires et al, who&#x000a0;presented a case of bacterial orbital abscess in a patient with COVID-19. Notably, the intraoperative findings of highly avascular nasal mucosa and cultures&#x000a0;yielded&#x000a0;<italic toggle="yes">Streptococcus constellatus </italic>and <italic toggle="yes">Peptonipihilus indolicus</italic>, bacteria ordinarily absent in the orbit or upper respiratory mucosa.<xref ref-type="bibr" rid="article-96178.r79">[79]</xref>&#x000a0;The local microbiologic and immunologic environment&#x000a0;could have been&#x000a0;altered due to avascularity induced by thrombosis in the setting of SARS-CoV-2 infection.</p>
        <p>A rising number of reports&#x000a0;have documented&#x000a0;acute invasive fungal rhino-orbital mucormycosis coinfection with COVID-19. These opportunistic pathogens thrive in the hypoxic respiratory environment induced by SARS-CoV-2 and an immunocompromised state induced by high-dose steroids and immunosuppressive therapies. The risk is further heightened in patients with poorly controlled diabetes, particularly those with diabetic ketoacidosis (DKA).<xref ref-type="bibr" rid="article-96178.r80">[80]</xref><xref ref-type="bibr" rid="article-96178.r81">[81]</xref><xref ref-type="bibr" rid="article-96178.r82">[82]</xref>&#x000a0;</p>
        <p>Singh et al&#x000a0;conducted a systematic review of 101 reported cases of COVID-19 patients with mucormycosis, revealing a predominantly male population (79%), with 80%&#x000a0;having diabetes and 15% with concomitant DKA.<xref ref-type="bibr" rid="article-96178.r83">[83]</xref> Corticosteroids had been&#x000a0;administered&#x000a0;in 76% of these patients, and nearly 60% of the cases reported rhino-orbital involvement.<xref ref-type="bibr" rid="article-96178.r83">[83]</xref>&#x000a0;Notably, orbital compartment syndrome due to concurrent COVID-19 and fulminant mucormycotic infection can also occur.<xref ref-type="bibr" rid="article-96178.r84">[84]</xref></p>
        <p>There have also been reports of MRI-proven orbital myositis in&#x000a0;2 separate COVID-19 patients&#x000a0;without&#x000a0;concurrent bacterial infection.<xref ref-type="bibr" rid="article-96178.r85">[85]</xref><xref ref-type="bibr" rid="article-96178.r86">[86]</xref>&#x000a0;The authors postulated that direct viral orbital invasion of the orbit or induced autoimmunity were possible mechanisms.</p>
        <p>Patients with positive SARS-CoV-2 antibodies can develop acute dacryoadenitis. Patients respond favorably to a slow taper of steroids over 6 weeks.<xref ref-type="bibr" rid="article-96178.r87">[87]</xref>&#x000a0;</p>
        <p>
<bold>Lacrimal System</bold>
</p>
        <p>Epiphora has been described as an initial finding in patients with COVID-19, believed to result from inflammation of the conjunctiva.<xref ref-type="bibr" rid="article-96178.r12">[12]</xref>&#x000a0;No reports have indicated direct involvement of the nasolacrimal system or the lacrimal sac in COVID-19.&#x000a0;</p>
        <p>
<bold>Manifestations in Newborn Infants</bold>
</p>
        <p>Recent data support the occurrence of frequent ocular manifestations of SARS-CoV-2 infection in newborn infants. In a study by Perez-Chimal et al conducted in Mexico, 15 infants with positive RT-PCR nasopharyngeal swabs were identified. All of these newborns exhibited ocular manifestations, periorbital edema being the most common (100%), followed by chemosis and hemorrhagic conjunctivitis (73%) and ciliary injection (53%). Unique findings included corneal edema in 6 infants (40%), 1 with rubeosis and posterior synechiae, and posterior segment manifestations, including retinopathy of prematurity in 3 infants (20%).<xref ref-type="bibr" rid="article-96178.r88">[88]</xref> Vitreous hemorrhage was observed in 1 full-term baby, and subtle cotton wool spots in 2 other newborns.</p>
      </sec>
      <sec id="article-96178.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A thorough history&#x000a0;is&#x000a0;essential, including&#x000a0;details about the symptoms' onset, duration, and&#x000a0;nature. Examination of the anterior segment using a slit lamp or at the bedside can confirm findings of conjunctivitis or episcleritis. Additionally, measuring visual acuity and intraocular pressure and performing a dilated fundus examination are warranted to rule out potentially more&#x000a0;severe ocular diseases.</p>
        <p>The examination should include a meticulous&#x000a0;assessment of the pupils and color testing to evaluate patients for evidence of optic neuropathy. Evaluation of extraocular motility may reveal evidence of nystagmus or cranial neuropathies. Additionally, visual field testing can detect and confirm deficits&#x000a0;associated with&#x000a0;stroke.</p>
        <p>SARS-CoV-2 can be detected via reverse transcription polymerase chain reaction (RT-PCR) using a virus sampling swab to sweep the lower eyelid fornices&#x000a0;and collect tears and conjunctival secretions.<xref ref-type="bibr" rid="article-96178.r13">[13]</xref>&#x000a0;A conjunctival&#x000a0;swab is the gold standard for tear collection and viral testing.<xref ref-type="bibr" rid="article-96178.r14">[14]</xref></p>
        <p>Additional serum or cerebrospinal fluid testing may be helpful to evaluate for inflammatory, autoimmune, or demyelinating entities. Neuroimaging can also provide valuable information, especially in patients with optic neuritis, visual field deficits, cranial neuropathies, or other associated neurologic symptoms.</p>
        <p>All patients should be&#x000a0;queried about recent fever, respiratory symptoms, exposure, and travel history to&#x000a0;determine the need for further evaluation&#x000a0;for COVID-19.&#x000a0;This comprehensive assessment helps identify potential cases and ensure appropriate management and precautions.</p>
      </sec>
      <sec id="article-96178.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Chen et al reported gradual symptomatic improvement of COVID-19 conjunctivitis in&#x000a0;1 patient with the administration of ribavirin eye drops.<xref ref-type="bibr" rid="article-96178.r89">[89]</xref>&#x000a0;While the efficacy of targeted treatment remains unstudied, its long-term significance in a self-limited viral illness is unlikely. Nonetheless, eye care providers should be&#x000a0;cautious and aim to reduce&#x000a0;possible viral load and potential transmission.<xref ref-type="bibr" rid="article-96178.r90">[90]</xref></p>
        <p>As with other viral infections, COVID-19 conjunctivitis is presumed to be self-limited and managed with symptomatic care. In the absence of significant eye pain, decreased vision, or light sensitivity, many patients can be managed remotely with a trial of frequent preservative-free artificial tears, cold compresses, and lubricating ophthalmic ointment. A short course of topical antibiotics may be considered to prevent or treat bacterial superinfection, especially in patients with symptoms and risk factors such as contact lens wear.<xref ref-type="bibr" rid="article-96178.r91">[91]</xref>&#x000a0;</p>
        <p>On March 18, 2020, the American Academy of Ophthalmology (AAO) issued guidance urging all ophthalmologists to&#x000a0;prioritize&#x000a0;urgent or emergent care to&#x000a0;minimize the risk of SARS-CoV-2 transmission and conserve disposable medical supplies. They outlined specific criteria&#x000a0;for determining the necessity of care (see <bold>Table.</bold>&#x000a0;AAO Risk Stratification for Clinic Ophthalmic Patients).&#x000a0;</p>
        <p>Although preliminary studies&#x000a0;indicate a low&#x000a0;risk of viral transmission through ocular secretions, comprehensive&#x000a0;large-scale research is lacking, and new data&#x000a0;continues to emerge&#x000a0;regularly. Therefore, healthcare providers are&#x000a0;strongly advised&#x000a0;to&#x000a0;maintain&#x000a0;proper protection of the eyes, nose, and mouth when examining patients. Given the nature and proximity of the ophthalmic examination, eye care providers and technicians may&#x000a0;face&#x000a0;increased susceptibility to infection.<xref ref-type="bibr" rid="article-96178.r92">[92]</xref>&#x000a0;</p>
        <p>Eye care providers should utilize slit lamp breath shields and&#x000a0;advise&#x000a0;patients to&#x000a0;minimize talking while seated at the slit lamp to minimize the risk of&#x000a0;virus transmission. Implementing rigorous disinfection and sterilization&#x000a0;protocols&#x000a0;for shared clinic equipment such as tonometers, trial frames, pinhole occluders, B-scan probes, and contact lenses for laser procedures is essential.<xref ref-type="bibr" rid="article-96178.r2">[2]</xref><xref ref-type="bibr" rid="article-96178.r92">[92]</xref>&#x000a0;Disposable barrier protection of clinic tools should be used where possible.</p>
        <table-wrap id="article-96178.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. AAO Risk Stratification for Clinic Ophthalmic Patients</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 27px;">
                <td style="height: 27px;" rowspan="1" colspan="1">Routine ophthalmic appointments, including those for chronic conditions, annual check-ups, and follow-ups, should be postponed until the severity of COVID-19 reduces, including new patients with chronic conditions such as cataracts or ptosis.</td>
              </tr>
              <tr style="height: 27px;">
                <td style="height: 27px;" rowspan="1" colspan="1">The consultant surgeon reviews new patient referrals to determine urgency. If necessary, he conducts telephone interviews with the referring doctor and/or the patient.&#x000a0;</td>
              </tr>
              <tr style="height: 87px;">
                <td style="height: 87px;" rowspan="1" colspan="1">
<p>All patients scheduled for a clinic visit are assessed for the following:</p>
<list list-type="bullet"><list-item><p>Presence of fever, cough, or shortness of breath</p></list-item><list-item><p>Any foreign travel or travel to areas with a high infection rate within the&#x000a0;past&#x000a0;14 days</p></list-item><list-item><p>Any contact with&#x000a0;individuals who have been diagnosed with COVID-19</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>If the patient exhibits 2 out of 3 of the symptoms noted above (see <bold>Table.</bold> AAO Risk Stratification for Clinic Ophthalmic Patients), they are referred for medical assessment. Patients with COVID-19 or symptoms such as fever, cough, or shortness of breath are examined in a separate isolation room. Ideally, only&#x000a0;1 person (physician, technician, etc) should be present in the room due to the small size of ophthalmic rooms, and they should wear complete personal protective equipment (PPE), including a gown, N95 mask, face shield, and gloves. Hands&#x000a0;should be washed before and after examination for a minimum of 20 seconds with soap and water.&#x000a0;After the ophthalmic examination, the patient is&#x000a0;referred for further assessment by the medical team.&#x000a0;</p>
        <p>
<bold>Protection of Medical Workers</bold>
</p>
        <p>While&#x000a0;the 2003 SARS-CoV crisis did not&#x000a0;lead to such widespread infection in the United States, healthcare workers accounted for about 20% of all patients with infections.<xref ref-type="bibr" rid="article-96178.r93">[93]</xref>&#x000a0;Recent data indicate&#x000a0;that&#x000a0;healthcare workers comprise 9% of COVID-10 cases in Italy.</p>
        <p>Between March 2020 and April 7, 2021, over 3699 healthcare workers in the United States succumbed to COVID-19, with the majority being&#x000a0;younger&#x000a0;than 60 years. As of April 7, 2021, Italy had recorded 129,873 coronavirus cases among healthcare workers, with&#x000a0;over 100 healthcare workers, including over 60 doctors, having died from COVID-19 infections by April 2020. Current figures are unavailable, but the numbers in other countries&#x000a0;are expected to&#x000a0;increase.&#x000a0;</p>
        <p>Ensuring that frontline medical workers wear appropriate protective gear is crucial. Additionally, monitoring these healthcare workers for signs of disease and implementing appropriate containment measures is essential.&#x000a0;</p>
        <p>A significant&#x000a0;number of deaths in the United States were&#x000a0;linked&#x000a0;to an initial severe shortage of appropriate PPE for healthcare providers. Even with the availability of PPE, selecting the level of protective gear based on the risk of infection is crucial. Suggestions are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ensure the waiting room maintains minimal occupancy, with available seating at least 6 feet apart.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>For patients who do not meet any of the 3 criteria mentioned above, healthcare workers&#x000a0;should wear a surgical mask, a face shield, and gloves and wash their&#x000a0;hands before and after each encounter.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>If a patient meets any of the&#x000a0;3 criteria, healthcare workers must wear full PPE, including a gown, face shield, gloves, and N95 mask.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Considering that droplets from sneezes can travel up to 6 meters, technicians from the Moran Eye Center have developed a slit-lamp shield using 2 plastic sheets through a laminator without paper in between, with openings cut for the eyepieces (see <bold>Image</bold>. Slit-Lamp Shield).<xref ref-type="bibr" rid="article-96178.r94">[94]</xref>&#x000a0;Others have&#x000a0;improvised using&#x000a0;old x-ray films&#x000a0;when commercial shields are in short supply.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>During consultations, conversations are kept to a minimum to reduce potential exposure.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Some institutions, faced with a shortage of surgical masks, have explored options such as storing used masks for potential resterilization at the end of each day.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Up to&#x000a0;a quarter of patients injected under sedation may&#x000a0;experience a severe involuntary sneeze, particularly common with eyelid injections.<xref ref-type="bibr" rid="article-96178.r95">[95]</xref><xref ref-type="bibr" rid="article-96178.r96">[96]</xref>&#x000a0;This is more common with eyelid injections than with retrobulbar injections. To mitigate this risk, ophthalmic surgeons must exercise caution and take appropriate precautions when administering a local anesthetic.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Surveillance&#x000a0;of Medical Workers</bold>
</p>
        <p>In Singapore, healthcare workers reported their temperatures twice a day via an online system, which proved to be a prudent approach. Conventional "walk-by" temperature testing may offer inaccurate or comprehensive results, particularly with staff arriving early or leaving late.<xref ref-type="bibr" rid="article-96178.r97">[97]</xref>&#x000a0;As of April 16, 2021, Singapore had recorded 60,769 infections and only 30 deaths attributable&#x000a0;to the virus.&#x000a0;</p>
        <p>All travel outside the state or country should be declared to the medical administration for review. This&#x000a0;protocol remains relevant&#x000a0;given the ongoing occurrence of infection in various states and countries. Additionally, all healthcare workers should promptly self-report symptoms&#x000a0;to facilitate appropriate testing. Isolation and contact tracing&#x000a0;measures can&#x000a0;then be&#x000a0;implemented as necessary.&#x000a0;</p>
        <p>
<bold>Sterilization of Equipment</bold>
</p>
        <p>After each patient, the slit-lamp shields are disinfected with 70% ethyl alcohol, as this concentration has been demonstrated to reduce coronavirus infectivity.<xref ref-type="bibr" rid="article-96178.r94">[94]</xref>&#x000a0;Slitlamps, B-scan probes, and other tools are cleaned&#x000a0;using 70% ethyl alcohol. Goldman tonometers undergo&#x000a0;sterilization with a 10% diluted sodium hypochlorite solution,&#x000a0;known to inactivate coronaviruses effectively.<xref ref-type="bibr" rid="article-96178.r98">[98]</xref></p>
      </sec>
      <sec id="article-96178.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Ocular manifestations of COVID-19&#x000a0;often&#x000a0;present&#x000a0;with conjunctivitis,&#x000a0;which can resemble other&#x000a0;viral etiologies. Common ocular manifestations that should be considered in the differential diagnosis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Viral conjunctivitis other than due to COVID-19 (eg, adenovirus)</p>
          </list-item>
          <list-item>
            <p>Bacterial conjunctivitis</p>
          </list-item>
          <list-item>
            <p>Allergic conjunctivitis</p>
          </list-item>
          <list-item>
            <p>Herpes simplex virus keratitis</p>
          </list-item>
          <list-item>
            <p>Anterior uveitis</p>
          </list-item>
          <list-item>
            <p>Corneal abrasion</p>
          </list-item>
          <list-item>
            <p>Foreign body</p>
          </list-item>
          <list-item>
            <p>Dry eye syndrome</p>
          </list-item>
          <list-item>
            <p>Exposure keratopathy in an intubated patient</p>
          </list-item>
          <list-item>
            <p>Chemosis in a critically ill patient</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-96178.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Conjunctivitis related to COVID-19 is considered self-limited, but additional research is necessary to comprehend the lasting effects of other ocular manifestations associated with the virus. Studies examining SARS-CoV-2 detection in ocular samples&#x000a0;have&#x000a0;suggested&#x000a0;a potentially&#x000a0;poorer prognosis&#x000a0;for patients&#x000a0;who test positive for the virus in ocular specimens.<xref ref-type="bibr" rid="article-96178.r99">[99]</xref>&#x000a0;</p>
        <p>Upon further evaluation of the study cohort, it was found that patients with a higher viral load or greater severity of acute illness were more prone to testing positive for viral RNA in ocular samples. Additionally, they were more likely to have underlying comorbidities that&#x000a0;correlated with a poorer 10-year survival rate.<xref ref-type="bibr" rid="article-96178.r99">[99]</xref>&#x000a0;</p>
        <p>The authors conclude that while ocular manifestations of COVID-19 do not&#x000a0;indicate decreased survival, they may&#x000a0;serve as a prognostic sign and a potential indicator of disease progression from moderate to&#x000a0;severe.<xref ref-type="bibr" rid="article-96178.r99">[99]</xref>&#x000a0;Further studies are&#x000a0;required to&#x000a0;assess this relationship more comprehensively.</p>
        <p>Clinical data&#x000a0;indicates the possibility of the virus spreading through tear samples of infected patients is low.<xref ref-type="bibr" rid="article-96178.r100">[100]</xref>&#x000a0;In a recent case series, only 1 out of 30 confirmed cases of COVID-19 illness had positive tear samples.&#x000a0;Similarly, in another&#x000a0;study where tear samples and nasopharyngeal swabs were tested simultaneously, nasopharyngeal swabs tested positive without any positive tear samples.<xref ref-type="bibr" rid="article-96178.r100">[100]</xref>&#x000a0;However, despite these findings, a review of currently available data suggests that transmission through the eyes is plausible, as&#x000a0;evidenced by viral RNA isolation from COVID-19 patients with high-viral loads and active conjunctivitis.<xref ref-type="bibr" rid="article-96178.r101">[101]</xref></p>
      </sec>
      <sec id="article-96178.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Most of the information regarding ocular manifestations of COVID-19 illness&#x000a0;comes from&#x000a0;small prospective cohorts or case studies.&#x000a0;While most suggest self-limited disease, the long-term prognosis and complication rate&#x000a0;remain&#x000a0;to be determined. However, some studies indicate that&#x000a0;mucormycosis may occur in these patients due to the immune dysregulation caused by COVID-19 infection and corticosteroid use for its treatment, especially in those with diabetes mellitus.<xref ref-type="bibr" rid="article-96178.r102">[102]</xref></p>
        <p>Compromised tear film quality, which has been reported as another potential complication of COVID-19 illness, can lead to dry eye syndrome and ocular surface damage, especially in hospitalized patients.<xref ref-type="bibr" rid="article-96178.r99">[99]</xref>&#x000a0;Prompt recognition and management of ocular complications, including dry eye syndrome, in patients with COVID-19 are essential to prevent long-term ocular sequelae and improve overall patient comfort and well-being.</p>
      </sec>
      <sec id="article-96178.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Prevention strategies&#x000a0;remain vital&#x000a0;in&#x000a0;controlling disease&#x000a0;transmission, emphasizing physical distancing,&#x000a0;regular hand-washing, and minimizing direct touching of the eyes and face. Despite the availability of vaccines and declining infection rates in certain regions, these measures remain essential to curb the potential resurgence of COVID-19 and other infectious diseases. Other&#x000a0;recommendations to consider&#x000a0;include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Avoiding the use of contact lenses</p>
          </list-item>
          <list-item>
            <p>Limiting the application of cosmetics around the eye</p>
          </list-item>
          <list-item>
            <p>Opting for glasses&#x000a0;or sunglasses</p>
          </list-item>
          <list-item>
            <p>Regularly changing sheets, pillowcases, and towels&#x000a0;to maintain cleanliness and hygiene</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-96178.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind regarding ophthalmic manifestations of COVID-19 include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ocular shedding of SARS-CoV-2 through tears is a potential concern for ophthalmologists.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Conjunctivitis or tearing may be some patients' initial or sole presentation of COVID-19.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Several ocular manifestations of COVID-19 have been observed, including retinovascular disease, uveitis, optic neuropathies, and orbital fungal coinfections (see <bold>Image.</bold> Fungal Endophthalmitis).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>SARS-CoV-2 may trigger or exacerbate inflammatory/demyelinating disease.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In advanced cases, patients may present with chemosis (see <bold>Image.&#x000a0;</bold>Chemosis) or follicular conjunctivitis (see <bold>Image.&#x000a0;</bold>Follicular Conjunctivitis).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>During ocular examinations, precautions such as wearing gloves and using extension instruments (eg, cotton swabs) should be taken to minimize direct contact with secretions.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Given that many ophthalmic clinic visitors are&#x000a0;older&#x000a0;and have underlying health conditions, careful screening for the necessity of in-person visits is crucial. Telemedicine is a viable alternative for non-urgent cases.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Implementing social distancing measures within clinical settings can be challenging. Still, efforts should be made to limit the number of individuals in examination rooms, with a preference for only&#x000a0;1 person accompanying the patient.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Certain medical specialties, such as ophthalmology, otolaryngology, and anesthesiology, may face increased infection risks due to close proximity to mucosal surfaces during examinations or procedures.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Surgical protocols, including delaying entry into operating rooms after intubation or extubation, aim to reduce transmission risks regardless of the patient's COVID-19 status.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-96178.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>In outpatient, inpatient, and surgical settings, effective management of COVID-19 patients and containment of the disease require an interprofessional approach. Clear communication among hospital administration, provider teams, and clinic support staff is essential to establish expectations for patient screening, proper utilization of PPE, and integration of telemedicine technologies for consultations.</p>
        <p>Identifying ocular manifestations of COVID-19 is crucial for early detection and effective management of patients with this disease. Therefore, all interprofessional healthcare team members (physicians, optometrists, advanced care practitioners, nurses, pharmacists) and other ancillary medical staff should be well-informed about these manifestations. Team members should feel empowered to raise concerns if they notice signs or symptoms suggestive of ocular involvement in a patient. Early recognition enables prompt intervention and contributes to improved patient outcomes. With close collaboration, healthcare professionals can enhance patient-centered care, promote patient safety, and optimize team performance in managing ophthalmic manifestations of COVID-19.&#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-96178.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=96178&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=96178">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/ophthalmic-manifestations-of-coronavirus-covid-19/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=96178">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/96178/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=96178">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-96178.s16">
        <fig id="article-96178.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Structure of COVID-19. This illustration, created by the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the virus's outer surface, which impart the look of a corona surrounding the virion when viewed electron microscopically. In this view, the protein particles E, S, and M, also located on the particle's outer surface, have all been labeled as well. A novel coronavirus, SARS-CoV-2, was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, in 2019. The infection caused by this virus has been named COVID-19. Contributed from the CDC, Alissa Eckert, MS; Dan Higgins, MAM (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="23313_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-96178.s17">
        <fig id="article-96178.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Slit-Lamp Shield. A slit-lamp shield, designed to protect the examiner, was created by Moran Technicians Stein Erickson, Emily Petersen, and Anna Reed, with assistance from others. It is constructed by passing&#x000a0;2 lamination sheets through a laminator without anything in between, resulting in a rigid shield that can be cleaned with alcohol and reused. Alternatively, used x-ray films may be utilized, although they lack the clarity required for optimal performance. Contributed on behalf of the Moran Eye Center by Katherine Hu, MD and Prof. BCK Patel, MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Slit-lamp__shield__-__BCK__Patel__MD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-96178.s18">
        <fig id="article-96178.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Chemosis. Conjunctival edema and inflammation can be seen with viral and bacterial infections after eyelid surgery, trauma, thyroid disease, and orbital tumors. Contributed by Prof. BCK Patel, MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Chemosis-BCK__Patel__MD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-96178.s19">
        <fig id="article-96178.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Follicular Conjunctivitis. May be seen with viral infections like herpes zoster, Epstein-Barr virus infection, infectious mononucleosis), chlamydial infections, and in reaction of topical medications and molluscum contagiosum. Follicular conjunctivitis has been described in patients with the COVID-19 infection (coronavirus infection). The inferior and superior tarsal conjunctiva and the fornices show gray-white elevated swellings, which are about 0.5 - 1 mm in diameter and have a velvety appearance. Contributed by Prof. BCK Patel MD, FRCS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Follicular__conjunctivitis-BCK__Patel__MD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-96178.s20">
        <fig id="article-96178.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Fungal Endophthalmitis. Color photography and fluorescein angiography of a patient with fungal endophthalmitis following COVID-19. Contributed by G Elnahry, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Post-COVID__fungal__endo" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-96178.s21">
        <title>References</title>
        <ref id="article-96178.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rajnik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aleem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dulebohn</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Di Napoli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Features, Evaluation, and Treatment of Coronavirus (COVID-19)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>18</day>
            <pub-id pub-id-type="pmid">32150360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Teoh</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Oon</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Se-Thoe</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Leo</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>The severe acute respiratory syndrome coronavirus in tears.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>88</volume>
            <issue>7</issue>
            <fpage>861</fpage>
            <page-range>861-3</page-range>
            <pub-id pub-id-type="pmid">15205225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raboud</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shigayeva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGeer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bontovics</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gravel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lapinsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Loeb</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Ofner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Paton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Scales</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Simor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vearncombe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zoutman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada.</article-title>
            <source>PLoS One</source>
            <year>2010</year>
            <month>May</month>
            <day>19</day>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>e10717</fpage>
            <pub-id pub-id-type="pmid">20502660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>XF</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>ZF</given-names>
              </name>
            </person-group>
            <article-title>2019-nCoV transmission through the ocular surface must not be ignored.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Feb</month>
            <day>22</day>
            <volume>395</volume>
            <issue>10224</issue>
            <fpage>e39</fpage>
            <pub-id pub-id-type="pmid">32035510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azzolini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Premi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siracusa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Genoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grossi</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Azzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sessa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dentali</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Severgnini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Minoja</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cabrini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chiaravalli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Veronesi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carcano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maffioli</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Tagliabue</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2021</year>
            <month>Sep</month>
            <day>01</day>
            <volume>139</volume>
            <issue>9</issue>
            <fpage>956</fpage>
            <page-range>956-963</page-range>
            <pub-id pub-id-type="pmid">33662099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seah</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2020</year>
            <month>Apr</month>
            <day>02</day>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>391</fpage>
            <page-range>391-395</page-range>
            <pub-id pub-id-type="pmid">32175797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>DSC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>DSW</given-names>
              </name>
            </person-group>
            <article-title>Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>104</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-298</page-range>
            <pub-id pub-id-type="pmid">32086236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiehzadegan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alaghemand</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Venketaraman</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Analysis of the Delta Variant B.1.617.2 COVID-19.</article-title>
            <source>Clin Pract</source>
            <year>2021</year>
            <month>Oct</month>
            <day>21</day>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>778</fpage>
            <page-range>778-784</page-range>
            <pub-id pub-id-type="pmid">34698149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferr&#x000e9;</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Peiffer-Smadja</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Visseaux</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Descamps</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ghosn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Charpentier</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Omicron SARS-CoV-2 variant: What we know and what we don't.</article-title>
            <source>Anaesth Crit Care Pain Med</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>100998</fpage>
            <pub-id pub-id-type="pmid">34902630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guan</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Ou</surname>
                <given-names>CQ</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>DSC</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yuen</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>NS</given-names>
              </name>
              <collab>China Medical Treatment Expert Group for Covid-19</collab>
            </person-group>
            <article-title>Clinical Characteristics of Coronavirus Disease 2019 in China.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Apr</month>
            <day>30</day>
            <volume>382</volume>
            <issue>18</issue>
            <fpage>1708</fpage>
            <page-range>1708-1720</page-range>
            <pub-id pub-id-type="pmid">32109013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasiri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharifi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bazrafshan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Noori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karamouzian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharifi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2021</year>
            <season>Jan-Mar</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-112</page-range>
            <pub-id pub-id-type="pmid">33520133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Duan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2020</year>
            <month>May</month>
            <day>01</day>
            <volume>138</volume>
            <issue>5</issue>
            <fpage>575</fpage>
            <page-range>575-578</page-range>
            <pub-id pub-id-type="pmid">32232433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.</article-title>
            <source>J Med Virol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>589</fpage>
            <page-range>589-594</page-range>
            <pub-id pub-id-type="pmid">32100876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Namaeh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ocular manifestations of COVID-19.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2022</year>
            <season>Jan-Dec</season>
            <volume>14</volume>
            <fpage>25158414221083374</fpage>
            <pub-id pub-id-type="pmid">35434520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrison</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.</article-title>
            <source>Trends Immunol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>12</issue>
            <fpage>1100</fpage>
            <page-range>1100-1115</page-range>
            <pub-id pub-id-type="pmid">33132005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Castiglione</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Soiberman</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Eberhart</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Duh</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.</article-title>
            <source>bioRxiv</source>
            <year>2020</year>
            <month>May</month>
            <day>09</day>
            <pub-id pub-id-type="pmid">32511393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Auw-Haedrich</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schlecht</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boneva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lapp</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Horres</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reinhard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schlunck</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Expression of the COVID-19 receptor ACE2 in the human conjunctiva.</article-title>
            <source>J Med Virol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>92</volume>
            <issue>10</issue>
            <fpage>2081</fpage>
            <page-range>2081-2086</page-range>
            <pub-id pub-id-type="pmid">32374427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colavita</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lapa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carletti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lalle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bordi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marsella</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nicastri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bevilacqua</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Giancola</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Corpolongo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ippolito</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Capobianchi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Castilletti</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection.</article-title>
            <source>Ann Intern Med</source>
            <year>2020</year>
            <month>Aug</month>
            <day>04</day>
            <volume>173</volume>
            <issue>3</issue>
            <fpage>242</fpage>
            <page-range>242-243</page-range>
            <pub-id pub-id-type="pmid">32302380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Jui-Ling Liu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Precaution and prevention of coronavirus disease 2019 infection in the eye.</article-title>
            <source>J Chin Med Assoc</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>83</volume>
            <issue>7</issue>
            <fpage>648</fpage>
            <page-range>648-650</page-range>
            <pub-id pub-id-type="pmid">32332516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dockery</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Rowe</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Krzystolik</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.</article-title>
            <source>J Emerg Med</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>137</fpage>
            <page-range>137-140</page-range>
            <pub-id pub-id-type="pmid">32456959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Sampritha</surname>
                <given-names>UC</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Adappa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chandraprabha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neeraja</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Guru Prasad</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Basumatary</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gangasagara</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Sujatha Rathod</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Jayanthi</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic manifestations in the COVID-19 clinical spectrum.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>691</fpage>
            <page-range>691-694</page-range>
            <pub-id pub-id-type="pmid">33595502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dom&#x000ed;nguez-Varela</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Guti&#x000e9;rrez</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Morales-Mancillas</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Barrera-S&#x000e1;nchez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mac&#x000ed;as-Rodr&#x000ed;guez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Valdez-Garc&#x000ed;a</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 and the eye: a review.</article-title>
            <source>Infect Dis (Lond)</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>399</fpage>
            <page-range>399-403</page-range>
            <pub-id pub-id-type="pmid">33566704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ulhaq</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Soraya</surname>
                <given-names>GV</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>258</volume>
            <issue>6</issue>
            <fpage>1351</fpage>
            <page-range>1351-1352</page-range>
            <pub-id pub-id-type="pmid">32328758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scalinci</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Trovato Battagliola</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Conjunctivitis can be the only presenting sign and symptom of COVID-19.</article-title>
            <source>IDCases</source>
            <year>2020</year>
            <volume>20</volume>
            <fpage>e00774</fpage>
            <pub-id pub-id-type="pmid">32373467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheema</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aghazadeh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nazarali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McFarlane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kanji</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Zelyas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Damji</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Solarte</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19).</article-title>
            <source>Can J Ophthalmol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>e125</fpage>
            <page-range>e125-e129</page-range>
            <pub-id pub-id-type="pmid">32284146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Navel</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chiambaretta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dutheil</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>19</volume>
            <fpage>100735</fpage>
            <pub-id pub-id-type="pmid">32377594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danthuluri</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Update and Recommendations for Ocular Manifestations of COVID-19 in Adults and Children: A Narrative Review.</article-title>
            <source>Ophthalmol Ther</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>853</fpage>
            <page-range>853-875</page-range>
            <pub-id pub-id-type="pmid">33058068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Otaif</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Al Somali</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Al Habash</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>20</volume>
            <fpage>100917</fpage>
            <pub-id pub-id-type="pmid">32923742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e9;ndez Mangana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barraquer Kargacin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barraquer</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Episcleritis as an ocular manifestation in a patient with COVID-19.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>98</volume>
            <issue>8</issue>
            <fpage>e1056</fpage>
            <page-range>e1056-e1057</page-range>
            <pub-id pub-id-type="pmid">32483943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feizi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meshksar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Naderi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esfandiari</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases.</article-title>
            <source>Cornea</source>
            <year>2021</year>
            <month>Sep</month>
            <day>01</day>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>1204</fpage>
            <page-range>1204-1206</page-range>
            <pub-id pub-id-type="pmid">34351874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazzotta</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Giancipoli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Anterior Acute Uveitis Report in a SARS-CoV-2 Patient Managed with Adjunctive Topical Antiseptic Prophylaxis Preventing 2019-nCoV Spread Through the Ocular Surface Route.</article-title>
            <source>Int Med Case Rep J</source>
            <year>2020</year>
            <volume>13</volume>
            <fpage>513</fpage>
            <page-range>513-520</page-range>
            <pub-id pub-id-type="pmid">33116943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bettach</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zadok</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weill</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Brosh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hanhart</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection.</article-title>
            <source>J Med Virol</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>93</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <page-range>139-140</page-range>
            <pub-id pub-id-type="pmid">32592496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanjay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mutalik</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gowda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahendradas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kawali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>"Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis".</article-title>
            <source>SN Compr Clin Med</source>
            <year>2021</year>
            <volume>3</volume>
            <issue>9</issue>
            <fpage>1843</fpage>
            <page-range>1843-1847</page-range>
            <pub-id pub-id-type="pmid">34124585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Fenaroli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Eberhart</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Duh</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes-Implications for Retinopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2021</year>
            <month>Jun</month>
            <day>01</day>
            <volume>62</volume>
            <issue>7</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">34086044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Araujo-Silva</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Marcos</surname>
                <given-names>AAA</given-names>
              </name>
              <name>
                <surname>Marinho</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Branco</surname>
                <given-names>AMC</given-names>
              </name>
              <name>
                <surname>Roque</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Matuoka</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Farah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burnier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moraes</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Tierno</surname>
                <given-names>PFGMM</given-names>
              </name>
              <name>
                <surname>Schor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Sousa</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Belfort</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2021</year>
            <month>Sep</month>
            <day>01</day>
            <volume>139</volume>
            <issue>9</issue>
            <fpage>1015</fpage>
            <page-range>1015-1021</page-range>
            <pub-id pub-id-type="pmid">34323931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walinjkar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Makhija</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Morekar</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Natarajan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Central retinal vein occlusion with COVID-19 infection as the presumptive etiology.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>68</volume>
            <issue>11</issue>
            <fpage>2572</fpage>
            <page-range>2572-2574</page-range>
            <pub-id pub-id-type="pmid">33120696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yahalomi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pikkel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arnon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pessach</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Central retinal vein occlusion in a young healthy COVID-19 patient: A case report.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>20</volume>
            <fpage>100992</fpage>
            <pub-id pub-id-type="pmid">33225111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acharya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anwar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tyagi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Unique case of central retinal artery occlusion secondary to COVID-19 disease.</article-title>
            <source>IDCases</source>
            <year>2020</year>
            <volume>21</volume>
            <fpage>e00867</fpage>
            <pub-id pub-id-type="pmid">32572363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montesel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bucolo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mouvet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moret</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Eandi</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient.</article-title>
            <source>Front Pharmacol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>588384</fpage>
            <pub-id pub-id-type="pmid">33424598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murchison</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Sweid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dharia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Theofanis</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Tjoumakaris</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Jabbour</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Bilyk</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Monocular visual loss as the presenting symptom of COVID-19 infection.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>201</volume>
            <fpage>106440</fpage>
            <pub-id pub-id-type="pmid">33383464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gascon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Briantais</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertrand</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ramtohul</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Comet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beylerian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sauvan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Swiader</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Durand</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Denis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Covid-19-Associated Retinopathy: A Case Report.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2020</year>
            <month>Nov</month>
            <day>16</day>
            <volume>28</volume>
            <issue>8</issue>
            <fpage>1293</fpage>
            <page-range>1293-1297</page-range>
            <pub-id pub-id-type="pmid">33021856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bottini</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Steinmetz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blinder</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Purtscher-Like Retinopathy in a Patient with COVID-19.</article-title>
            <source>Case Rep Ophthalmol Med</source>
            <year>2021</year>
            <volume>2021</volume>
            <fpage>6661541</fpage>
            <pub-id pub-id-type="pmid">33859855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>EZ</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Purtscher-like retinopathy in a patient with COVID-19 and disseminated intravascular coagulation.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>24</volume>
            <fpage>101229</fpage>
            <pub-id pub-id-type="pmid">34796309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marinho</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Marcos</surname>
                <given-names>AAA</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Belfort</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Retinal findings in patients with COVID-19.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>May</month>
            <day>23</day>
            <volume>395</volume>
            <issue>10237</issue>
            <fpage>1610</fpage>
            <pub-id pub-id-type="pmid">32405105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Invernizzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Torre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parrulli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zicarelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schiuma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Giacomelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cigada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Milazzo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ridolfo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Faggion</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cordier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oldani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rizzardini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Antinori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Staurenghi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Meroni</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Retinal findings in patients with COVID-19: Results from the SERPICO-19 study.</article-title>
            <source>EClinicalMedicine</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>27</volume>
            <fpage>100550</fpage>
            <pub-id pub-id-type="pmid">32984785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lecler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lersy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>H&#x000e9;ran</surname>
                <given-names>F</given-names>
              </name>
              <collab>SFNR's COVID Study Group</collab>
            </person-group>
            <article-title>Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study.</article-title>
            <source>Radiology</source>
            <year>2021</year>
            <month>May</month>
            <volume>299</volume>
            <issue>2</issue>
            <fpage>E226</fpage>
            <page-range>E226-E229</page-range>
            <pub-id pub-id-type="pmid">33591889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Souza</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>de Campos</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Atypical unilateral multifocal choroiditis in a COVID-19 positive patient.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>22</volume>
            <fpage>101034</fpage>
            <pub-id pub-id-type="pmid">33623832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goyal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Annum</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Bilateral Multifocal Choroiditis following COVID-19 Vaccination.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2021</year>
            <month>May</month>
            <day>19</day>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>753</fpage>
            <page-range>753-757</page-range>
            <pub-id pub-id-type="pmid">34344280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Provid&#x000ea;ncia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Henriques</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Proen&#x000e7;a</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Serpiginous choroiditis presenting after SARS-CoV-2 infection: A new immunological trigger?</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>NP97</fpage>
            <page-range>NP97-NP101</page-range>
            <pub-id pub-id-type="pmid">33267645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tom</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Saraf</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection.</article-title>
            <source>Case Rep Ophthalmol Med</source>
            <year>2021</year>
            <volume>2021</volume>
            <fpage>1646364</fpage>
            <pub-id pub-id-type="pmid">34367705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Narayanan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tyagi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Belenje</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acute Retinal Necrosis as a presenting ophthalmic manifestation in COVID 19 recovered patients.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2021</year>
            <month>May</month>
            <day>19</day>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>722</fpage>
            <page-range>722-725</page-range>
            <pub-id pub-id-type="pmid">34228583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chin</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Hooks</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Detrick</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Identification of &#x003b1;-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR).</article-title>
            <source>J Neuroimmunol</source>
            <year>2014</year>
            <month>Jul</month>
            <day>15</day>
            <volume>272</volume>
            <issue>1-2</issue>
            <fpage>42</fpage>
            <page-range>42-50</page-range>
            <pub-id pub-id-type="pmid">24864013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Detrick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chesky</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hooks</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>The role of apoptosis within the retina of coronavirus-infected mice.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>3011</fpage>
            <page-range>3011-8</page-range>
            <pub-id pub-id-type="pmid">10967058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinores</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vinores</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Derevjanik</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Detrick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hooks</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains.</article-title>
            <source>J Neuroimmunol</source>
            <year>2001</year>
            <month>Oct</month>
            <day>01</day>
            <volume>119</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-82</page-range>
            <pub-id pub-id-type="pmid">11585619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu&#x000ed;s</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hip&#x000f3;lito-Fernandes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mota</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maleita</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cunha</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Tavares Ferreira</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection.</article-title>
            <source>Eye Brain</source>
            <year>2020</year>
            <volume>12</volume>
            <fpage>129</fpage>
            <page-range>129-137</page-range>
            <pub-id pub-id-type="pmid">33154692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawalha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Adeodokun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kamoga</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>COVID-19-Induced Acute Bilateral Optic Neuritis.</article-title>
            <source>J Investig Med High Impact Case Rep</source>
            <year>2020</year>
            <season>Jan-Dec</season>
            <volume>8</volume>
            <fpage>2324709620976018</fpage>
            <pub-id pub-id-type="pmid">33238757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jones-Lopez</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Soneji</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Azevedo</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>VR</given-names>
              </name>
            </person-group>
            <article-title>Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>398</fpage>
            <page-range>398-402</page-range>
            <pub-id pub-id-type="pmid">32604245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Ruijter</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gons</surname>
                <given-names>RAR</given-names>
              </name>
              <name>
                <surname>Hengstman</surname>
                <given-names>GJD</given-names>
              </name>
            </person-group>
            <article-title>Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.</article-title>
            <source>Mult Scler Relat Disord</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>46</volume>
            <fpage>102474</fpage>
            <pub-id pub-id-type="pmid">32892062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leber</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Sant'Ana</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Konichi da Silva</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Raio</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mazzeo</surname>
                <given-names>TJMM</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Acute Thyroiditis and Bilateral Optic Neuritis following SARS-CoV-2 Vaccination with CoronaVac: A Case Report.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2021</year>
            <month>Aug</month>
            <day>18</day>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>1200</fpage>
            <page-range>1200-1206</page-range>
            <pub-id pub-id-type="pmid">34402726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-D&#x000ed;az</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gracia-Gil</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Romero-S&#x000e1;nchez</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>D&#x000ed;az-Maroto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Segura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Multiple sclerosis following SARS-CoV-2 infection.</article-title>
            <source>Mult Scler Relat Disord</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>45</volume>
            <fpage>102377</fpage>
            <pub-id pub-id-type="pmid">32698095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavalcanti</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Raz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dehkharghani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yaghi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lillemoe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nossek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Riina</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Radmanesh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Cerebral Venous Thrombosis Associated with COVID-19.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>8</issue>
            <fpage>1370</fpage>
            <page-range>1370-1376</page-range>
            <pub-id pub-id-type="pmid">32554424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baccarella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jonokuchi</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Maldonado-Soto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boneparth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hooe</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Schweickert</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Carlin</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Kingery</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Sewell</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19.</article-title>
            <source>Pediatr Neurol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>115</volume>
            <fpage>48</fpage>
            <page-range>48-49</page-range>
            <pub-id pub-id-type="pmid">33333460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verkuil</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Brahma</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Avery</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Pseudotumor cerebri syndrome associated with MIS-C: a case report.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Aug</month>
            <day>22</day>
            <volume>396</volume>
            <issue>10250</issue>
            <fpage>532</fpage>
            <pub-id pub-id-type="pmid">32795406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belghmaidi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nassih</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boutgayout</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>El Fakiri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>El Qadiry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hajji</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bourrahouate</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moutaouakil</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Third Cranial Nerve Palsy Presenting with Unilateral Diplopia and Strabismus in a 24-Year-Old Woman with COVID-19.</article-title>
            <source>Am J Case Rep</source>
            <year>2020</year>
            <month>Oct</month>
            <day>15</day>
            <volume>21</volume>
            <fpage>e925897</fpage>
            <pub-id pub-id-type="pmid">33056942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>RMC</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Olivetti</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Bilateral trochlear nerve palsy due to cerebral vasculitis related to COVID-19 infection.</article-title>
            <source>Arq Neuropsiquiatr</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>78</volume>
            <issue>6</issue>
            <fpage>385</fpage>
            <page-range>385-386</page-range>
            <pub-id pub-id-type="pmid">32609196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greer</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Dinkin</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Isolated Cranial Nerve 6 Palsy in 6 Patients With COVID-19 Infection.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>520</fpage>
            <page-range>520-522</page-range>
            <pub-id pub-id-type="pmid">32941331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinkin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bobker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Simonetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harpe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mints</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salama</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tsiouris</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Leifer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.</article-title>
            <source>Neurology</source>
            <year>2020</year>
            <month>Aug</month>
            <day>04</day>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>221</fpage>
            <page-range>221-223</page-range>
            <pub-id pub-id-type="pmid">32358218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Restivo</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Centonze</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alesina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marchese-Ragona</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Myasthenia Gravis Associated With SARS-CoV-2 Infection.</article-title>
            <source>Ann Intern Med</source>
            <year>2020</year>
            <month>Dec</month>
            <day>15</day>
            <volume>173</volume>
            <issue>12</issue>
            <fpage>1027</fpage>
            <page-range>1027-1028</page-range>
            <pub-id pub-id-type="pmid">32776781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogozinski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Puppe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Framme</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>H&#x000f6;glinger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hufendiek</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wegner</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient.</article-title>
            <source>Front Neurol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>576153</fpage>
            <pub-id pub-id-type="pmid">33123081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortiz-Seller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez Costa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Pons</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valls Pascual</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Solves Alemany</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Albert-Fort</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19).</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2020</year>
            <month>Nov</month>
            <day>16</day>
            <volume>28</volume>
            <issue>8</issue>
            <fpage>1285</fpage>
            <page-range>1285-1289</page-range>
            <pub-id pub-id-type="pmid">33021422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ord&#x000e1;s</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Villacieros-&#x000c1;lvarez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pastor-Vivas</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Corrales-Ben&#x000ed;tez</surname>
                <given-names>&#x000c1;</given-names>
              </name>
            </person-group>
            <article-title>Concurrent tonic pupil and trochlear nerve palsy in COVID-19.</article-title>
            <source>J Neurovirol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>970</fpage>
            <page-range>970-972</page-range>
            <pub-id pub-id-type="pmid">32910433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaya Tutar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kale</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tugcu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Adie-Holmes syndrome associated with COVID-19 infection: A case report.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>773</fpage>
            <page-range>773-774</page-range>
            <pub-id pub-id-type="pmid">33595525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malayala</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Raza</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A Case of COVID-19-Induced Vestibular Neuritis.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Jun</month>
            <day>30</day>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>e8918</fpage>
            <pub-id pub-id-type="pmid">32760619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Craik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Makan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dev</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moudgil</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2020</year>
            <month>May</month>
            <day>15</day>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>293</fpage>
            <page-range>293-294</page-range>
            <pub-id pub-id-type="pmid">32371417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Llorente Ayuso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Torres Rubio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Beijinho do Ros&#x000e1;rio</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Giganto Arroyo</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Sierra-Hidalgo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Bickerstaff encephalitis after COVID-19.</article-title>
            <source>J Neurol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>268</volume>
            <issue>6</issue>
            <fpage>2035</fpage>
            <page-range>2035-2037</page-range>
            <pub-id pub-id-type="pmid">32880723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merkler</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Mir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kamel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lantos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schenck</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bruce</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lansdale</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>LeMoss</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Stieg</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Iadecola</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Cusick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campion</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Navi</surname>
                <given-names>BB</given-names>
              </name>
            </person-group>
            <article-title>Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.</article-title>
            <source>JAMA Neurol</source>
            <year>2020</year>
            <month>Jul</month>
            <day>02</day>
            <volume>77</volume>
            <issue>11</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">32614385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkinson</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Etheridge</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Swiston</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Vegunta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wiggins</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>JEA</given-names>
              </name>
            </person-group>
            <article-title>Bilateral Posterior Cerebral Artery Stroke from COVID-Related Multisystem Inflammatory Syndrome in a Child.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>e548</fpage>
            <page-range>e548-e550</page-range>
            <pub-id pub-id-type="pmid">34812758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turbin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Wawrzusin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Sakla</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Traba</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Mirani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eloy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nimchinsky</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.</article-title>
            <source>Orbit</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>305</fpage>
            <page-range>305-310</page-range>
            <pub-id pub-id-type="pmid">32419568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shires</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Klug</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dryden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Unusual cause of acute sinusitis and orbital abscess in COVID-19 positive patient: Case report.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>79</volume>
            <fpage>164</fpage>
            <page-range>164-168</page-range>
            <pub-id pub-id-type="pmid">33477076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mekonnen</surname>
                <given-names>ZK</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Jankowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Grob</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Vagefi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kersten</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Simko</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Winn</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <string-date>2021 Mar-Apr 01</string-date>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>e40</fpage>
            <page-range>e40-e80</page-range>
            <pub-id pub-id-type="pmid">33229953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Rhino-Orbital Mucormycosis Associated With COVID-19.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Sep</month>
            <day>30</day>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>e10726</fpage>
            <pub-id pub-id-type="pmid">33145132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lahane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lahane</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Parekh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Honavar</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Mucor in a Viral Land: A Tale of Two Pathogens.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>244</fpage>
            <page-range>244-252</page-range>
            <pub-id pub-id-type="pmid">33463566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.</article-title>
            <source>Diabetes Metab Syndr</source>
            <year>2021</year>
            <season>Jul-Aug</season>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>102146</fpage>
            <pub-id pub-id-type="pmid">34192610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Werthman-Ehrenreich</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mucormycosis with orbital compartment syndrome in a patient with COVID-19.</article-title>
            <source>Am J Emerg Med</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>42</volume>
            <fpage>264.e5</fpage>
            <page-range>264.e5-264.e8</page-range>
            <pub-id pub-id-type="pmid">32972795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Murchison</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Bilyk</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Suspected orbital myositis associated with COVID-19.</article-title>
            <source>Orbit</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>532</fpage>
            <page-range>532-535</page-range>
            <pub-id pub-id-type="pmid">34402364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eleiwa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Abdelrahman</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>ElSheikh</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Elhusseiny</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Orbital inflammatory disease associated with COVID-19 infection.</article-title>
            <source>J AAPOS</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>232</fpage>
            <page-range>232-234</page-range>
            <pub-id pub-id-type="pmid">33965589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez D&#x000ed;az</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Copete Piqueras</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blanco Marchite</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vahdani</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Acute dacryoadenitis in a patient with SARS-CoV-2 infection.</article-title>
            <source>Orbit</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>374</fpage>
            <page-range>374-377</page-range>
            <pub-id pub-id-type="pmid">33402004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Chimal</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Cuevas</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Di-Luciano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chamart&#x000ed;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Amadeo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Castellanos</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic manifestations associated with SARS-CoV-2 in newborn infants: a preliminary report.</article-title>
            <source>J AAPOS</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-104</page-range>
            <pub-id pub-id-type="pmid">33601042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>104</volume>
            <issue>6</issue>
            <fpage>748</fpage>
            <page-range>748-751</page-range>
            <pub-id pub-id-type="pmid">32265202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amesty</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ali&#x000f3; Del Barrio</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ali&#x000f3;</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 Disease and Ophthalmology: An Update.</article-title>
            <source>Ophthalmol Ther</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">32445134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varu</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Akpek</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Amescua</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Farid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Garcia-Ferrer</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Musch</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Mah</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>SP</given-names>
              </name>
              <collab>American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel</collab>
            </person-group>
            <article-title>Conjunctivitis Preferred Practice Pattern&#x000ae;.</article-title>
            <source>Ophthalmology</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>126</volume>
            <issue>1</issue>
            <fpage>P94</fpage>
            <page-range>P94-P169</page-range>
            <pub-id pub-id-type="pmid">30366797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seah</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lingam</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Revisiting the dangers of the coronavirus in the ophthalmology practice.</article-title>
            <source>Eye (Lond)</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>7</issue>
            <fpage>1155</fpage>
            <page-range>1155-1157</page-range>
            <pub-id pub-id-type="pmid">32029919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lun</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>SARS: a timely reminder.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>9</issue>
            <fpage>1217</fpage>
            <page-range>1217-8</page-range>
            <pub-id pub-id-type="pmid">23793905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xie</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chwang</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Seto</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve.</article-title>
            <source>Indoor Air</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-25</page-range>
            <pub-id pub-id-type="pmid">17542834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wessels</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Wessels</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>The photic sneeze reflex and ocular anesthesia.</article-title>
            <source>Ophthalmic Surg Lasers</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>208</fpage>
            <page-range>208-11</page-range>
            <pub-id pub-id-type="pmid">10100255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morley</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jazayeri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Factors prompting sneezing in intravenously sedated patients receiving local anesthetic injections to the eyelids.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>May</month>
            <volume>117</volume>
            <issue>5</issue>
            <fpage>1032</fpage>
            <page-range>1032-6</page-range>
            <pub-id pub-id-type="pmid">20079540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jun</surname>
                <given-names>ISY</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>KKO</given-names>
              </name>
              <name>
                <surname>Songbo</surname>
                <given-names>PZ</given-names>
              </name>
            </person-group>
            <article-title>Perspectives on Coronavirus Disease 2019 Control Measures for Ophthalmology Clinics Based on a Singapore Center Experience.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2020</year>
            <month>May</month>
            <day>01</day>
            <volume>138</volume>
            <issue>5</issue>
            <fpage>435</fpage>
            <page-range>435-436</page-range>
            <pub-id pub-id-type="pmid">32232466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kampf</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Todt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pfaender</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Steinmann</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</article-title>
            <source>J Hosp Infect</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>104</volume>
            <issue>3</issue>
            <fpage>246</fpage>
            <page-range>246-251</page-range>
            <pub-id pub-id-type="pmid">32035997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sabage</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sabage</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mazzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Manzoni Louren&#x000e7;one</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Conjunctival Swabs Reveal Higher Detection Rate Compared to Schirmer Strips for SARS-CoV-2 RNA Detection in Tears of Hospitalized COVID-19 Patients.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Nov</month>
            <day>24</day>
            <volume>11</volume>
            <issue>23</issue>
            <pub-id pub-id-type="pmid">36498504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies.</article-title>
            <source>Adv Ophthalmol Pract Res</source>
            <year>2023</year>
            <season>Feb-Mar</season>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-38</page-range>
            <pub-id pub-id-type="pmid">36471811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thankam</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Ocular transmissibility of COVID-19: possibilities and perspectives.</article-title>
            <source>Mol Cell Biochem</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>477</volume>
            <issue>3</issue>
            <fpage>849</fpage>
            <page-range>849-864</page-range>
            <pub-id pub-id-type="pmid">35066705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96178.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Upadhya</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, Clinical Features and Management of Rhino Orbital Mucormycosis in Post COVID 19 Patients.</article-title>
            <source>Indian J Otolaryngol Head Neck Surg</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-107</page-range>
            <pub-id pub-id-type="pmid">34414101</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
